Nghiên cứu đặc điểm lâm sàng và kết quả điều trị xuất huyết dịch kính trong bệnh võng mạc đái tháo đường

Objectives: To describe the clinical features and to evaluate the treatment results of diabetic vitreous hemorrhage. Subjects: Patients of diabetic vitreous hemorrhage were treated in the Retinal Department, VNIO from 3/2011 to 8/2011. Cases with retinal detachment and neovascular glaucoma were excluded. Methods: Prospective clinical trial study. Study process: clinical and paraclinical exyminations to grade the hemorrhage. Treatment: medical treatment was evaluated in 1 week postoperative about the anatomical and functional results, intraoperative and postoperative complications were evaluated. Results: Duration of diabetes from 5 - 10 years is 32.3 percent, more than 10 years is 51.6 percent. Nearly 80 percent of patients had gade II or III hemorrhage and 84.2 percent had VA 20/400. Anatomical result at 1 month postoperatively: good outcome was 52.6 percent; moderate was 39.5 percent; poor was 7.9 percent. Functional result: VA 20/400 was 84.2 percent preoperatively reduced from to 2.6 percent at 1 month postoperatively. At discharge VA 2: 20/200 is increased by 5.3 percent at discharge, by 65.8 percent at 1 week, by 68.4 percent at 1 month, compared with preoperative. The only intraoperative complication was been recurrent bleeding in 7.9 percent of cases. No postoperative complications. Conclusion: Vitreous hemorrhage was a severe complication for which the vitrectomy could result in functional and anatomical improvement.